Clinical Trial Update: Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus [Phase 4]

View source ↗

Summary

Phase 4 trial update on Lantus (insulin glargine) evaluating metabolic and economic outcomes in diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED